ENHANCED HUMORAL IMMUNITY IN COMMON VARIABLE IMMUNODEFICIENCY AFTER LONG-TERM TREATMENT WITH POLYETHYLENE GLYCOL-CONJUGATED INTERLEUKIN-2

被引：34

作者：

CUNNINGHAMRUNDLES, C

KAZBAY, K

HASSETT, J

ZHOU, Z

MAYER, L

机构：

[1] Division of Clinical Immunology, Department of Medicine, Mount Sinai Medical Center, New York. NY 1002

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1994年 / 331卷 / 14期

关键词：

D O I：

10.1056/NEJM199410063311405

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：918 / 921

页数：4

共 36 条

[1] DIRECT EFFECT OF INTERLEUKIN-2 ON THE DIFFERENTIATION OF HUMAN B-CELLS WHICH HAVE NOT BEEN PREACTIVATED INVITRO [J].

BICHTHUY, LT ;

FAUCI, AS .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1985, 15 (11) :1075-1079

[2]

BUCKLEY RH, 1991, NEW ENGL J MED, V325, P110, DOI 10.1056/NEJM199107113250207

[3] T-CELL HELP IN HUMAN ANTIGEN-SPECIFIC ANTIBODY-RESPONSES CAN BE REPLACED BY INTERLEUKIN-2 [J].

CALLARD, RE ;

SMITH, SH ;

SHIELDS, JG ;

LEVINSKY, RJ .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (09) :1037-1042

[4] CLINICAL AND IMMUNOLOGICAL ANALYSES OF 103 PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY [J].

CUNNINGHAMRUNDLES, C .

JOURNAL OF CLINICAL IMMUNOLOGY, 1989, 9 (01) :22-33

[5] RESTORATION OF IMMUNOGLOBULIN SECRETION INVITRO IN COMMON VARIABLE IMMUNODEFICIENCY BY INVIVO TREATMENT WITH POLYETHYLENE GLYCOL-CONJUGATED HUMAN RECOMBINANT INTERLEUKIN-2 [J].

CUNNINGHAMRUNDLES, C ;

MAYER, L ;

SAPIRA, E ;

MENDELSOHN, L .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 64 (01) :46-56

[6]

CUNNINGHAMRUNDLES C, 1993, CLIN RES, V41, pA369

[7] DEFECTIVE INTERLEUKIN-2 AND INTERFERON-GAMMA GENE-EXPRESSION IN RESPONSE TO ANTIGEN IN A SUBGROUP OF PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY [J].

FISCHER, MB ;

HAUBER, I ;

VOGEL, E ;

WOLF, HM ;

MANNHALTER, JW ;

EIBL, MM .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 92 (02) :340-352

[8]

GILLIS S, 1978, J IMMUNOL, V120, P2027

[9] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].

GRIMM, EA ;

MAZUMDER, A ;

ZHANG, HZ ;

ROSENBERG, SA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1823-1841

[10] CHEMICAL MODIFICATION OF RECOMBINANT INTERLEUKIN-2 BY POLYETHYLENE-GLYCOL INCREASES ITS POTENCY IN THE MURINE METH-A SARCOMA MODEL [J].

KATRE, NV ;

KNAUF, MJ ;

LAIRD, WJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (06) :1487-1491

← 1 2 3 4 →